Correlation Between Oxford Nanopore and Cadrenal Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Oxford Nanopore and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oxford Nanopore and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oxford Nanopore Technologies and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on Oxford Nanopore and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oxford Nanopore with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oxford Nanopore and Cadrenal Therapeutics,.

Diversification Opportunities for Oxford Nanopore and Cadrenal Therapeutics,

-0.41

Correlation Coefficient

Oxford Nanopore  Cadrenal Therapeutics,

Very good diversification

The 3 months correlation between Oxford and Cadrenal is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Oxford Nanopore Technologies and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and Oxford Nanopore is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oxford Nanopore Technologies are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of Oxford Nanopore i.e., Oxford Nanopore and Cadrenal Therapeutics, go up and down completely randomly.

Pair Corralation between Oxford Nanopore and Cadrenal Therapeutics,

Assuming the 90 days horizon Oxford Nanopore Technologies is expected to under-perform the Cadrenal Therapeutics,. But the pink sheet apears to be less risky and, when comparing its historical volatility, Oxford Nanopore Technologies is 1.62 times less risky than Cadrenal Therapeutics,. The pink sheet trades about 0.0 of its potential returns per unit of risk. The Cadrenal Therapeutics, Common is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  773.00  in Cadrenal Therapeutics, Common on September 14, 2024 and sell it today you would earn a total of  347.00  from holding Cadrenal Therapeutics, Common or generate 44.89% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Oxford Nanopore Technologies  vs.  Cadrenal Therapeutics, Common

Oxford Nanopore Tech

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Oxford Nanopore Technologies are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Oxford Nanopore reported solid returns over the last few months and may actually be approaching a breakup point.

Cadrenal Therapeutics,

Risk-Adjusted Performance

2 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Cadrenal Therapeutics, Common are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent forward-looking signals, Cadrenal Therapeutics, exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Oxford Nanopore and Cadrenal Therapeutics,

The main advantage of trading using opposite Oxford Nanopore and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oxford Nanopore position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.

The idea behind Oxford Nanopore Technologies and Cadrenal Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.